Container Closure Integrity Testing Solutions For Biologics

medical-pharma research-robotic pipette device

Developments in non-destructive, deterministic testing technologies that can achieve optimum assurance in container closure for biologics.

Biotechnology and pharmaceutical companies both produce medicines to treat conditions and save lives, but the medicines made by biotechnology companies are derived from living organisms while those made by pharmaceutical companies generally are produced using a synthetic process and are chemical based. Biotech and pharma markets are important industry sectors, sharing many broad similarities. The research & development of the fast growing Biotech industry accounts for many breakthrough life-saving treatments and vaccines for common diseases and conditions.

Cell & gene therapies encompass a wide range of therapeutic treatments that have emerged in recent years including stem cell treatments, genetic editing, tissue regeneration, among many others. These treatments emerging from the Biotechnology industry have fundamentally different properties than traditional medicines. They are often “live active product” or living drugs that can heal and replace diseased or damaged organs. Consequently, cell and gene therapy products are transforming the treatment of cancers and genetic diseases. Additionally, cell and gene therapies are rapidly expanding into other areas of medicine including autoimmune diseases, cardiovascular diseases, musculoskeletal disease, dermatological diseases and many others.

Packaging and drug delivery methods for these products are commonly parenteral packaging - pre-filled syringes, vials, cartridges, IV bags and other single use bags.

PTI Packaging and Inspection Systems